CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 81 enrolled
Drug / intervention
albuteroldrug
Likely dose
albuterol 180mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00940927
NCT00940927Phase 4Completed
CompareCT.gov

Exclusion of Asthmatics From Clinical Trials Due to the 15 Percent Rule

Nemours Children's Clinic·interventional·Posted Jul 17, 2009·Updated May 5, 2015

In Brief

A Phase 4 clinical trial evaluating albuterol for Asthma. Completed, enrolled 81 participants across 1 site.

Detailed Summary

The purpose of this study was to determine the lung function response after increasing doses of albuterol (a bronchodilator) in children and adults with asthma.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 17, 2009
Enrollment StartJul 1, 1993
Primary CompletionOct 1, 1994
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 17.0 years ago

Interventions

albuteroldrug

Albuterol administered sequentially 180mcg (MDI), 90mcg (MDI), 90mcg(MDI), 90mcg (MDI), 90mcg (MDI), 2.5mg (nebulized)